HROW·415858109·US·equity·Healthcare - Drug Manufacturers - Specialty & Generic-Activist
HROW (HARROW INC) is held by 102 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($90M), STATE STREET CORP ($30.1M), GEODE CAPITAL MANAGEMENT, LLC ($30M). Net institutional sentiment: Mixed.
See how HROW's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer